Kore Private Wealth’s Antares Pharma, Inc. ATRS Stock Holding History

Kore Private Wealth’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$41K	–	349
2022 Q1	$41K	Hold	10,000	–	–	0.01%	316
2021 Q4	$36K	Sell	10,000 -220	-2%	-$769	﹤0.01%	302
2021 Q3	$37K	Hold	10,220	–	–	﹤0.01%	443
2021 Q2	$45K	Buy	10,220 +220	+2%	+$896	0.01%	419
2021 Q1	$41K	Hold	10,000	–	–	0.01%	366
2020 Q4	$40K	Hold	10,000	–	–	0.01%	333
2020 Q3	$27K	Hold	10,000	–	–	0.01%	270
2020 Q2	$27K	Hold	10,000	–	–	0.01%	593
2020 Q1	$24K	Hold	10,000	–	–	0.01%	562
2019 Q4	$47K	Buy	+10,000	New	+$40.9K	0.01%	495

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Kore Private Wealth's ATRS Position: Q2 2022 in Review

Kore Private Wealth sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 10,000 shares — an estimated $41K sold.

Kore Private Wealth first reported a position in ATRS in Q4 2019 and held it in 10 quarters. The position peaked at $47K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Kore Private Wealth reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Kore Private Wealth sold 10,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $41K.
Kore Private Wealth first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 10 quarters.
Kore Private Wealth's Antares Pharma, Inc. position peaked at $47K in Q4 2019.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Kore Private Wealth's 13F filing for Q2 2022, filed 15 Aug 2022.